A detailed X-Linked Severe Combined Immunodeficiency (X-SCID) Market Share Analysis, Growth Opportunities, and Challenges


X-linked severe combined immunodeficiency (X-SCID) is an inherited disorder of the immune system that occurs almost exclusively in males. Boys with X-linked SCID are prone to recurrent and persistent infections because they lack the necessary immune cells to fight off certain bacteria, viruses, and fungi. Many infants with X-linked SCID develop chronic diarrhea, a fungal infection called thrush, and skin rashes. Affected individuals also grow more slowly than other children. Without treatment, males with X-linked SCID usually do not live beyond infancy. 

Mutations in the IL2RG gene cause X-linked SCID. The IL2RG gene provides instructions for making a protein that is critical for normal immune system function. This protein is necessary for the growth and maturation of developing immune system cells called lymphocytes. Lymphocytes defend the body against potentially harmful invaders, make antibodies, and help regulate the entire immune system. Mutations in the IL2RG gene prevent these cells from developing and functioning normally. Without functional lymphocytes, the body is unable to fight off infections. 

DelveInsight’s “X-Linked Severe Combined Immunodeficiency (X-SCID) Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the X-Linked Severe Combined Immunodeficiency (X-SCID), historical and forecasted epidemiology as well as the X-Linked Severe Combined Immunodeficiency (X-SCID) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

Some of the key facts of the X-Linked Severe Combined Immunodeficiency (X-SCID) Market Report: 

  • As per the Immune Deficiency Foundation 2019, The most common form of SCID, affecting nearly 45% of all cases, is due to a mutation in a gene on the X chromosome that encodes a component (or chain) shared by the T-cell growth factor receptor and other growth factor receptors 

  • Graphical Representation of X-Linked Severe Combined Immunodeficiency Epidemiology

  • Incident Cases of X-Linked Severe Combined Immunodeficiency in the 7MM 

  • X-linked Severe Combined Immunodeficiency (X-SCID) disorder is a fatal disease without any curative therapy approved to date. The current goals of treatment include prophylaxis for infections and preemptive bone marrow transplant (BMT) before the development of symptoms 

  • The only treatment for X-linked SCID currently available is Bone Marrow Transplant (BMT). The temporary management of the disease involves the treatment of infections using Immunoglobulins and antibiotics 

  • The focus of the Researchers is mainly on the development of Gene therapy for the treatment of X-Linked SCID

Request a sample for the Report: https://www.delveinsight.com/sample-request/xlinked-severe-combined-immunodeficiency-scid-market

X-Linked Severe Combined Immunodeficiency (X-SCID) Symptoms:

The symptoms of X-Linked Severe Combined Immunodeficiency (X-SCID) include –

  • Oral/diaper candidiasis

  • Absent tonsils and lymph nodes

  • Rashes

  • Diarrhea

  • High Fever

  • Pneumonia

Epidemiology Segmentation of X-Linked Severe Combined Immunodeficiency:

  • Prevalent Cases of X-Linked Severe Combined Immunodeficiency in the 7MM [2019-2032]

  • Age-Specific Cases of X-Linked Severe Combined Immunodeficiency in the 7MM [2019–2032]

  • Gender-Specific Cases of X-Linked Severe Combined Immunodeficiency in the 7MM [2019–2032]

  • Diagnosed and Treated Cases of X-Linked Severe Combined Immunodeficiency in the 7MM [2019–2032]

X-Linked Severe Combined Immunodeficiency (X-SCID) Market 

The dynamics of the X-Linked Severe Combined Immunodeficiency (X-SCID) market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Palifermin, Busulfan, and others during the forecasted period 2019-2032. 

Learn more by requesting for sample @X-Linked Severe Combined Immunodeficiency (X-SCID) Market Landscape  

X-Linked Severe Combined Immunodeficiency (X-SCID) Pipeline Therapies: 

  • Palifermin

  • Busulfan

  • Increlex

Gene-Transduced Autologous 

X-Linked Severe Combined Immunodeficiency (X-SCID) Pipeline Key Companies:

National Institutes of Health Clinical Center (CC)

National Institute of Allergy and Infectious Diseases (NIAID) 

Click here to read more about X-Linked Severe Combined Immunodeficiency (X-SCID) Market Outlook 2032 

Related Reports: 

X-Linked Severe Combined Immunodeficiency (X-SCID) Pipeline  

"X-Linked Severe Combined Immunodeficiency (X-SCID) Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the X-Linked Severe Combined Immunodeficiency (X-SCID) market. A detailed picture of the X-Linked Severe Combined Immunodeficiency (X-SCID) pipeline landscape is provided, which includes the disease overview and X-Linked Severe Combined Immunodeficiency (X-SCID) treatment guidelines. 

X-Linked Severe Combined Immunodeficiency (X-SCID) Epidemiology 

DelveInsight's 'X-Linked Severe Combined Immunodeficiency (X-SCID) Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted X-Linked Severe Combined Immunodeficiency (X-SCID) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

 

Diagnostic Imaging Equipment Market

 

Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.

 

Invasive Candidiasis Market

 

"DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.

 

Sialidosis Market 

 

DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Filgrastim Biosimilar Insight

 

DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. 

 

Pain Management Devices Market

 

Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 

Latest Reports by DelveInsight

Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market |  Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market


To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

https://www.delveinsight.com/consulting/competitive-intelligence-services

 

Comments

Post a Comment

Popular posts from this blog

Pharma Professional's Guide: GCC's 2024 Top Conference Picks

Image
The Gulf Cooperation Council (GCC) region has evolved into a vibrant nucleus for the pharmaceutical industry, witnessing substantial growth in recent times. With an unwavering focus on research and pioneering innovations, GCC nations have magnetized pharmaceutical professionals worldwide. In the upcoming year, 2024, the GCC will host several pivotal pharmaceutical conferences, offering an extensive platform for networking, knowledge dissemination, and exploring industry breakthroughs. This article presents an insightful glimpse into the top 10 pharmaceutical conferences scheduled in the GCC for 2024, with a spotlight on DUPHAT, securing a notable position at number 3. 1. Arab Health Date: January 29 - February 1, 2024 Location: Dubai World Trade Centre, UAE Website: Arab Health Arab Health stands as the Middle East's largest healthcare and pharmaceutical exhibition and congress. It serves as an encompassing platform for healthcare professionals to exchange ideas and explore the lat
Read more

Exploring the Global Condom Market: Drivers and Developments

Image
  What is a Condom? A condom is a barrier contraceptive device made of latex, polyurethane, or lambskin that is designed to prevent the transmission of sexually transmitted infections (STIs) and unintended pregnancies. It is one of the most widely used methods of protection during sexual activity. What is the market for Global Condom? The global Condom market is robust and continues to witness significant growth. This market is driven by the dual benefits of protection against STIs and contraception. Moreover, the market is evolving with the introduction of innovative and user-friendly condom designs, attracting a broader demographic. What are the Condom market drivers? The Condom Market Drivers are illustrated as follows- 1. Public Health Initiatives: Public health campaigns promoting safe sex and the prevention of STIs and unintended pregnancies drive condom use. 2. Increasing Awareness: Growing awareness of the importance of safe sex practices and the benefits of condom use fue
Read more

What is Type 2 Diabetes and emerging therapies in the Treatment Landscape?

Image
A chronic metabolic illness called diabetes is characterized by high or low blood glucose (also known as blood sugar) levels in the body. Diabetes significantly increases the risk of renal failure, heart attacks, strokes, blindness, and lower limb amputation. It can also have a substantial impact on a number of organs, including the heart, blood vessels, eyes, kidneys, skin, and nerves. Diabetic patients and their families may experience a variety of socioeconomic effects. It is typically regarded as a sickness of the wealthy, with a high frequency in developed nations. However, the picture for global prevalence is drastically changing. It is currently a rapidly expanding issue in less affluent areas as well as in low- and middle-income nations. The management of diabetes greatly benefits from technological advancements. Diabetes Prevalence and Overview According to estimates, the number of people with diabetes increased from 108 million in 1980 to 422 million in 2014, and between 20
Read more